The carcinogenic effect of various multi-walled carbon nanotubes (MWCNTs) after intraperitoneal injection in rats

Particle and Fibre Toxicology

Volumn 11, Issue 1, 2014, Pages

  Rittinghausen, Susanne ^a   Hackbarth, Anja ^a   Creutzenberg, Otto ^a   Ernst, Heinrich ^a   Heinrich, Uwe ^a   Leonhardt, Albrecht ^b   Schaudien, Dirk ^a  

^a FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^b IFW DRESDEN   (Germany)

Author keywords

Carbon nanotubes; Carcinogenicity; Intraperitoneal injection; Mesothelioma; MWCNT; Nanotoxicology; Rats

Indexed keywords

AMOSITE; ASBESTOS; CYTOKERATIN; MULTI WALLED NANOTUBE; PODOPLANIN; VIMENTIN; CARBON NANOTUBE; CARCINOGEN; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENIC ACTIVITY; CARCINOGENICITY; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MESOTHELIOMA; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; WISTAR RAT; ABDOMINAL TUMOR; ANIMAL; CARCINOGEN TESTING; CHEMICALLY INDUCED; CHEMISTRY; COMPARATIVE STUDY; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; PARTICLE SIZE; PATHOLOGY; SCANNING ELECTRON MICROSCOPY; SEROSA; SURVIVAL; TUMOR INVASION; ULTRASTRUCTURE;

ABDOMINAL NEOPLASMS; ANIMALS; CARCINOGENICITY TESTS; CARCINOGENS; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; MALE; MESOTHELIOMA; MICROSCOPY, ELECTRON, SCANNING; NANOTUBES, CARBON; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PARTICLE SIZE; RATS, WISTAR; SEROUS MEMBRANE; SURVIVAL ANALYSIS;

EID: 84923067699     PISSN: None     EISSN: 17438977     Source Type: Journal    
DOI: 10.1186/s12989-014-0059-z     Document Type: Article

References (62)

1. World Health Organisation WHO: Reference Methods for Measuring Airborne Man-Made Mineral Fibres (MMMF), WHO/EURO MMMF Reference Scheme, WHO Technical Committee for Monitoring and Evaluating Airborne MMMF. Copenhagen: WHO Regional Office for Europe; 1985.
2. Miller BG, Searl A, Donaldson K, Cullen RT, Bolton RE, Buchanan D, Soutar CA: Influence of fibre length, dissolution and biopersistence on the production of mesothelioma in the rat peritoneal cavity. Ann Occup Hyg 1999, 43:155-166.
3. Donaldson K, Poland CA, Murphy FA, MacFarlane M, Chernova T, Schinwald A: Pulmonary toxicity of carbon nanotubes and asbestos-similarities and differences. Adv Drug Deliv Rev 2013, 65:2078-2086.
4. Mossman B, Light W, Wei E: Asbestos: mechanisms of toxicity and carcinogenicity in the respiratory tract. Ann Rev Pharm Tox 1983, 23:595-615.
5. Jasani B, Gibbs A: Mesothelioma not associated with asbestos exposure. Arch Pathol Lab Med 2012, 136:262-267.
6. Muhle H, Pott F, Bellmann B, Takenaka S, Ziem U: Inhalation and injection experiments in rats to test the carcinogenicity of MMMF. Ann Occup Hyg 1987, 31:755-757.
7. JRC EUR 18748 EN-European Commission Joint Research Centre: II3. Carcinogenicity of synthetic mineral fibres after intraperitoneal injection in rats. In Methods for the determination of the hazardous properties for human health of Man Made Mineral Fibres (MMMF). ECB/TM/18(97) rev. Edited by Bernstein DM, Sintes JMR. Ispra, Italy: European Commission Joint Research Centre, Institute for Health and Consumer Protection; 1999.
8. SCOEL: Recommendation from the Scientific Committee on Occupational Exposure Limits for man-made mineral fibres (MMMF) with no indication for carcinogenicity and not specified elsewhere. SCOEL/SUM/88 2012, 2012:1-17.
9. Pott F, Roller M, Rippe RM, German P-G, Bellmann B: Tumours by the Intraperitoneal and Intrapleural Routes and Their Significance for the Classification of Mineral Fibres. In Mechanisms in Fibre Carcinogenesis. Edited by Brown RC, Hoskins JA, Johnson NF. New York: Plenum Press; 1991:547-565.
10. Hou PX, Xu ST, Ying Z, Yang QH, Liu C, Cheng HM: Hydrogen adsorption/desorption behavior of multi-walled carbon nanotubes with different diameters. Carbon 2003, 41:2471-2476.
11. Donaldson K, Aitken R, Tran L, Stone V, Duffin R, Forrest G, Alexander A: Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol Sci 2006, 92:5-22.
12. Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WA, Seaton A, Stone V, Brown S, Macnee W, Donaldson K: Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 2008, 3:423-428.
13. Takagi A, Hirose A, Nishimura T, Fukumori N, Ogata A, Ohashi N, Kitajima S, Kanno J: Induction of mesothelioma in p53+/-mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci 2008, 33:105-116.
14. Muller J, Delos M, Panin N, Rabolli V, Huaux F, Lison D: Absence of carcinogenic response to multiwall carbon nanotubes in a 2-year bioassay in the peritoneal cavity of the rat. Toxicol Sci 2009, 110:442-448.
15. Nagai H, Okazaki Y, Chew SH, Misawa N, Yamashita Y, Akatsuka S, Ishihara T, Yamashita K, Yoshikawa Y, Yasui H, Jiang L, Ohara H, Takahashi T, Ichihara G, Kostarelos K, Miyata Y, Shinohara H, Toyokuni S: Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis. Proc Natl Acad Sci U S A 2011, 108:E1330-E1338.
16. Davis JM, Bolton RE, Miller BG, Niver K: Mesothelioma dose response following intraperitoneal injection of mineral fibres. Int J Exp Pathol 1991, 72:263-274.
17. Porter D, Sriram K, Wolfarth M, Jefferson A, Schwegler-Berry D, Andrew ME, Castranova V: A biocompatible medium for nanoparticle dispersion. Nanotoxicology 2008, 2:144-154.
18. Carthew P, Hill RJ, Edwards RE, Lee PN: Intrapleural administration of fibres induces mesothelioma in rats in the same relative order of hazard as occurs in man after exposure. Hum Exp Toxicol 1992, 11:530-534.
19. Rittinghausen S, Ernst H, Muhle H, Mohr U: Atypical malignant mesotheliomas with osseous and cartilaginous differentiation after intraperitoneal injection of various types of mineral fibres in rats. Exp Toxicol Pathol 1992, 44:55-58.
20. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E: Histological typing of lung and pleural tumours. World Health Organization 1999, 3:25-66.
21. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y: The new world health organization classification of lung tumours. Eur Respir J 2001, 18:1059-1068.
22. Greaves P, Chouinard L, Ernst H, Mecklenburg L, Pruimboom-Brees IM, Rinke M, Rittinghausen S, Thibault S, Von Erichsen J, Yoshida T: Proliferative and non-proliferative lesions of the rat and mouse soft tissue, skeletal muscle and mesothelium. J Toxicol Pathol 2013, 26(3 Suppl):1S-26S.
23. Yaziji H, Battifora H, Barry TS, Hwang HC, Bacchi CE, McIntosh MW, Kussick SJ, Gown AM: Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity. Mod Pathol 2006, 19:514-523.
24. Fassina A, Cappellesso R, Guzzardo V, Dalla Via L, Piccolo S, Ventura L, Fassan M: Epithelial-mesenchymal transition in malignant mesothelioma. Mod Pathol 2012, 25:86-99. Epub 2011 Oct 7.
25. Marchevsky AM: Application of immunohistochemistry to the diagnosis of malignant mesothelioma. Arch Pathol Lab Med 2008, 132:397-401.
26. Husain AN, Colby TV, Ordóñez NG, Krausz T, Borczuk A, Cagle PT, Chirieac LR, Churg A, Galateau-Salle F, Gibbs AR, Gown AM, Hammar SP, Litzky LA, Roggli VL, Travis WD, Wick MR: Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the international mesothelioma interest group. Arch Pathol Lab Med 2009, 133:1317-1331.
27. Husain AN, Colby T, Ordóñez N, Krausz T, Attanoos R, Beasley MB, Borczuk AC, Butnor K, Cagle PT, Chirieac LR, Churg A, Dacic S, Fraire A, Galateau-Salle F, Gibbs A, Gown A, Hammar S, Litzky L, Marchevsky AM, Nicholson AG, Roggli V, Travis WD, Wick M: International mesothelioma interest group. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the international mesothelioma interest group. Arch Pathol Lab Med 2013, 137:647-667.
28. Chirieac LR, Pinkus GS, Pinkus JL, Godleski J, Sugarbaker DJ, Corson JM: The immunohistochemical characterization of sarcomatoid malignant mesothelioma of the pleura. Am J Cancer Res 2011, 1:14-24. Epub 2010 Sep 30.
29. Ordóñez NG: What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update. Hum Pathol 2007, 38:1-16. Epub 2006 Oct 23.
30. Ordóñez NG: Mesothelioma with signet-ring cell features: report of 23 cases. Mod Pathol 2013, 26:370-384. Epub 2012 Oct 5.
31. Abe S, Morita Y, Kaneko MK, Hanibuchi M, Tsujimoto Y, Goto H, Kakiuchi S, Aono Y, Huang J, Sato S, Kishuku M, Taniguchi Y, Azuma M, Kawazoe K, Sekido Y, Yano S, Akiyama S, Sone S, Minakuchi K, Kato Y, Nishioka Y: A novel targeting therapy of malignant mesothelioma using anti-podoplanin antibody. J Immunol 2013, 190:6239-6249.
32. Ohnuma-Koyama A, Yoshida T, Takahashi N, Akema S, Takeuchi-Kashimoto Y, Kuwahara M, Nagaike M, Inui K, Nakashima N, Harada T: Malignant peritoneal mesothelioma with a sarcomatoid growth pattern and signet-ring-like structure in a female F344 rat. J Toxicol Pathol 2013, 26:197-201.
33. Donaldson K, Murphy FA, Duffin R, Poland CA: Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol 2010, 7:5.
34. Tomatis M, Turci F, Ceschino R, Riganti C, Gazzano E, Martra G, Ghigo D, Fubini B: High aspect ratio materials: role of surface chemistry vs. length in the historical "long and short amosite asbestos fibers". Inhal Toxicol 2010, 22:984-998.
35. van Berlo D, Clift MJ, Albrecht C, Schins RP: Carbon nanotubes: an insight into the mechanisms of their potential genotoxicity. Swiss Med Wkly 2012, 142:w13698.
36. Gasser M, Wick P, Clift MJ, Blank F, Diener L, Yan B, Gehr P, Krug HF, Rothen-Rutishauser B: Pulmonary surfactant coating of multi-walled carbon nanotubes (MWCNTs) influences their oxidative and pro-inflammatory potential in vitro. Part Fibre Toxicol 2012, 9:17.
37. Hamilton RF Jr, Wu Z, Mitra S, Shaw PK, Holian A: Effect of MWCNT size, carboxylation, and purification on in vitro and in vivo toxicity, inflammation and lung pathology. Part Fibre Toxicol 2013, 10:57.
38. Ali-Boucetta H, Nunes A, Sainz R, Herrero MA, Tian B, Prato M, Bianco A, Kostarelos K: Asbestos-like pathogenicity of long carbon nanotubes alleviated by chemical functionalization. Angew Chem Int Ed 2013, 52:2274-2278.
39. Mercer RR, Hubbs AF, Scabilloni JF, Wang L, Battelli LA, Schwegler-Berry D, Castranova V, Porter DW: Distribution and persistence of pleural penetrations by multi-walled carbon nanotubes. Part Fibre Toxicol 2010, 7:28.
40. Huang SX, Jaurand MC, Kamp DW, Whysner J, Hei TK: Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases. J Toxicol Environ Health B Crit Rev 2011, 14:179-245.
41. Sargent LM, Shvedova AA, Hubbs AF, Salisbury JL, Benkovic SA, Kashon ML, Lowry DT, Murray AR, Kisin ER, Friend S, McKinstry KT, Battelli L, Reynolds SH: Induction of aneuploidy by single-walled carbon nanotubes. Environ Mol Mutagen 2009, 50:708-717.
42. Siegrist KJ, Reynolds SH, Kashon ML, Lowry DT, Dong C, Hubbs AF, Young SH, Salisbury JL, Porter DW, Benkovic SA, McCawley M, Keane MJ, Mastovich JT, Bunker KL, Cena LG, Sparrow MC, Sturgeon JL, Dinu CZ, Sargent LM: Genotoxicity of multi-walled carbon nanotubes at occupationally relevant doses. Part Fibre Toxicol 2014, 11:6.
43. Varga C, Szendi K: Carbon nanotubes induce granulomas but not mesotheliomas. In Vivo 2010, 24:153-156.
44. Takanashi S, Hara K, Aoki K, Usui Y, Shimizu M, Haniu H, Ogihara N, Ishigaki N, Nakamura K, Okamoto M, Kobayashi S, Kato H, Sano K, Nishimura N, Tsutsumi H, Machida K, Saito N: Carcinogenicity evaluation for the application of carbon nanotubes as biomaterials in rasH2 mice. Sci Rep 2012, 2:498. Erratum in: Sci Rep 2013, 3:1688.
45. Roe FJ, Carter RL, Walters MA, Harington JS: The pathological effects of subcutaneous injections of asbestos fibres in mice: migration of fibres to submesothelial tissues and induction of mesotheliomata. Int J Cancer 1967, 2:628-638.
46. Takagi A, Hirose A, Futakuchi M, Tsuda H, Kanno J: Dose-dependent mesothelioma induction by intraperitoneal administration of multi-wall carbon nanotubes in p53 heterozygous mice. Cancer Sci 2012, 103:1440-1444.
47. Sakamoto Y, Nakae D, Fukumori N, Tayama K, Maekawa A, Imai K, Hirose A, Nishimura T, Ohashi N, Ogata A: Induction of mesothelioma by a single intrascrotal administration of multi-wall carbon nanotube in intact male Fischer 344 rats. J Toxicol Sci 2009, 34:65-76.
48. Nagai H, Okazaki Y, Chew SH, Misawa N, Miyata Y, Shinohara H, Toyokuni S: Intraperitoneal administration of tangled multiwalled carbon nanotubes of 15 nm in diameter does not induce mesothelial carcinogenesis in rats. Pathol Int 2013, 63:457-462.
49. Pauluhn J: Multi-walled carbon nanotubes (Baytubes): approach for derivation of occupational exposure limit. Regul Toxicol Pharmacol 2010, 57:78-89.
50. Ma-Hock L, Strauss V, Treumann S, Küttler K, Wohlleben W, Hofmann T, Gröters S, Wiench K, van Ravenzwaay B, Landsiedel R: Comparative inhalation toxicity of multi-wall carbon nanotubes, graphene, graphite nanoplatelets and low surface carbon black. Part Fibre Toxicol 2013, 10:1-19.
51. Hubbs AF, Mercer RR, Benkovic SA, Harkema J, Sriram K, Schwegler-Berry D, Goravanahally MP, Nurkiewicz TR, Castranova V, Sargent LM: Nanotoxicology-a pathologist's perspective. Toxicol Pathol 2011, 39:301-324. Epub 2010 Dec 14.
52. Schinwald A, Murphy FA, Prina-Mello A, Poland CA, Byrne F, Movia D, Glass JR, Dickerson JC, Schultz DA, Jeffree CE, Macnee W, Donaldson K: The threshold length for fiber-induced acute pleural inflammation: shedding light on the early events in asbestos-induced mesothelioma. Toxicol Sci 2012, 128:461-470.
53. Grimaldi A, Moriondo A, Sciacca L, Guidali ML, Tettamanti G, Negrini D: Functional arrangement of rat diaphragmatic initial lymphatic network. Am J Physiol Heart Circ Physiol 2006, 291:H876-H885.
54. Michailova K, Wassilev W, Wedel T: Scanning and transmission electron microscopic study of visceral and parietal peritoneal regions in the rat. Ann Anat 1999, 181:253-260.
55. Li YY, Li JC: Ultrastructural study of pleural lymphatic drainage unit and effect of nitric oxide on the drainage capacity of pleural lymphatic stomata in the rat. Ann Anat 2004, 186:25-31.
56. Wang ZB, Li M, Li JC: Recent advances in the research of lymphatic stomata. Anat Rec (Hoboken) 2010, 293:754-761.
57. Abu-Hijleh MF, Habbal OA, Moqattash ST: The role of the diaphragm in lymphatic absorption from the peritoneal cavity. J Anat 1995, 186(Pt 3):453-467.
58. Azzali G: The transendothelial passage in the absorbing peripheral lymphatic vessel of the rodent diaphragm. Ital J Anat Embryol 1995, 100(Suppl 1):287-298.
59. Sargent LM, Porter DW, Staska LM, Hubbs AF, Lowry DT, Battelli L, Siegrist KJ, Kashon ML, Mercer RR, Bauer AK, Chen BT, Salisbury JL, Frazer D, McKinney W, Andrew M, Tsuruoka S, Endo M, Fluharty KL, Castranova V, Reynolds SH: Promotion of lung adenocarcinoma following inhalation exposure to multi-walled carbon nanotubes. Part Fibre Toxicol 2014, 11:3.
60. Blackshear PE, Pandiri AR, Ton TV, Clayton NP, Shockley KR, Peddada SD, Gerrish KE, Sills RC, Hoenerhoff MJ: Spontaneous mesotheliomas in F344/N rats are characterized by dysregulation of cellular growth and immune function pathways. Toxicol Pathol 2013, 42:863-876.
61. National Toxicology Program: NTP Historical controls report. All routes and vehicles. Wistar Han rats. June 2013. US Department of Health and Human Services; 2013 [http://ntp.niehs.nih.gov/ntp/historical_controls/ntp2000_2013/histcont2013_whanrats_allroutes_508.pdf]
62. TRGS 905: Technical rules for hazardous substances 905. Technical Rules (TRGS) established by the Committee on Hazardous Substances (AGS). Verzeichnis krebserzeugender, erbgutverändernder oder fortpflanzungsgefährdender Stoffe. German Federal Institute for Occupational Safety and Health (BAuA) 2014, 24:3-4.